Ona Therapeutics is focused on the discovery and development of therapeutic biologics to treat metastatic cancer.
Ona Therapeutics has raised €104M across 2 funding rounds from 10 investors, most recently a Series B round in Jun 2026. Based in Barcelona, Spain; founded 2019; active in Healthtech. Data as of 6 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2026-06-04 | Series B | €74M | Alta Life Sciences,Asabys Partners,Bpifrance,CDTI,COFIDES,Columbus Venture Partners+4 more | View deal → |
| 2020-06-16 | Series A | €30M | — | View deal → |
